Alumis (ALMS)
Develops oral TYK2 therapies for immune-mediated diseases in the body and brain.
$10.14
Pre-market−0.18 (−1.74%)
At close$10.32(+8.98%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
estimated · in 70 days
EPS estimate
−$0.73
Revenue estimate
$1.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$1.82−$1.17−$1.06−$0.95−$0.74—−$1.11Pending
Estimate−$1.47−$1.11−$0.92−$0.97−$0.79−$0.73−$0.77−$0.73
Surprise−23.8%−5.4%−15.2%+2.1%+6.3%—−44.7%—
RevenueReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported$17.4M$2.7M$2.1M$1.9M$1.7M$1.7M$1.7MPending
Estimate$1.7M$3.1M$2.8M$2.4M$2.1M$3.5M$3.7M$1.9M
Surprise+943.3%−15.2%−24.9%−18.4%−15.4%−52.1%−54.5%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.73 | — | — |
| Aug 2026 | −$0.77 | −$1.11 | −44.7% |
| Aug 2026 | −$0.73 | — | — |
| May 2026 | −$0.79 | −$0.74 | +6.3% |
| Mar 2026 | −$0.97 | −$0.95 | +2.1% |
The latest year is open to everyone — the 11 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.73 | — | — | $1.9M | — | — | — |
| Aug 13, 2026 | −$0.77 | −$1.11 | −44.7% | $3.7M | $1.7M | −54.5% | +3.7% |
| Aug 12, 2026 | −$0.73 | — | — | $3.5M | $1.7M | −52.1% | −4.5% |
| May 14, 2026 | −$0.79 | −$0.74 | +6.3% | $2.1M | $1.7M | −15.4% | −7.2% |
| Mar 19, 2026 | −$0.97 | −$0.95 | +2.1% | $2.4M | $1.9M | −18.4% | −1.3% |
The latest year is open to everyone — the 11 quarters behind it read with an account. Sign in | |||||||
| Nov 13, 2025 | |||||||
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 19, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| Mar 31, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 29, 2023 | |||||||
| Mar 31, 2023 | |||||||